Literature DB >> 8612629

Folding and activation of human procathepsin S from inclusion bodies produced in Escherichia coli.

G Kopitar1, M Dolinar, B Strukelj, J Pungercar, V Turk.   

Abstract

Human procathepsin S was produced in the form of insoluble inclusion bodies in Escherichia coli using an inducible T7-based expression system. After cell disruption, the dissolved inclusion body proteins were S-sulphonated with 2-nitro-5-thiosulphobenzoate and purified by gel filtration. Recombinant procathepsin S was renatured at pH 7.6 by a two-step dilution which significantly increased the yield of production compared to single-step dilution. The proenzyme was autocatalytically processed to active cathepsin S at pH 4.5 in the presence of an excess of cysteine and catalytic amounts of dextran sulphate. Most of the loss of procathepsin S occurred during folding, probably because of aggregation. Concentrations lower than 20 microgram/ml of procathepsin S were necessary to minimise such aggregation. The recombinant cathepsin S was catalytically active on fluorogenic substrates and had kinetic properties similar to those of recombinant enzyme produced in yeast. The expression, renaturation, and activation procedures used enable the production of up to 2 mg of catalytically active recombinant human cathepsin S/l fermentation broth.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612629     DOI: 10.1111/j.1432-1033.1996.00558.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

Review 1.  Approaches for the generation of active papain-like cysteine proteases from inclusion bodies of Escherichia coli.

Authors:  Chunfang Ling; Junyan Zhang; Deqiu Lin; Ailin Tao
Journal:  World J Microbiol Biotechnol       Date:  2015-03-20       Impact factor: 3.312

2.  Efficient co-expression of a recombinant staphopain A and its inhibitor staphostatin A in Escherichia coli.

Authors:  Benedykt Wladyka; Katarzyna Puzia; Adam Dubin
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

Review 3.  Optimizing dentin bond durability: control of collagen degradation by matrix metalloproteinases and cysteine cathepsins.

Authors:  Leo Tjäderhane; Fabio D Nascimento; Lorenzo Breschi; Annalisa Mazzoni; Ivarne L S Tersariol; Saulo Geraldeli; Arzu Tezvergil-Mutluay; Marcela R Carrilho; Ricardo M Carvalho; Franklin R Tay; David H Pashley
Journal:  Dent Mater       Date:  2012-08-16       Impact factor: 5.304

4.  Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis.

Authors:  J Kos; A Sekirnik; G Kopitar; N Cimerman; K Kayser; A Stremmer; W Fiehn; B Werle
Journal:  Br J Cancer       Date:  2001-10-19       Impact factor: 7.640

Review 5.  Cysteine cathepsin activity regulation by glycosaminoglycans.

Authors:  Marko Novinec; Brigita Lenarčič; Boris Turk
Journal:  Biomed Res Int       Date:  2014-12-21       Impact factor: 3.411

Review 6.  Novel Opportunities for Cathepsin S Inhibitors in Cancer Immunotherapy by Nanocarrier-Mediated Delivery.

Authors:  Natalie Fuchs; Mergim Meta; Detlef Schuppan; Lutz Nuhn; Tanja Schirmeister
Journal:  Cells       Date:  2020-09-02       Impact factor: 6.600

Review 7.  Cathepsin S: investigating an old player in lung disease pathogenesis, comorbidities, and potential therapeutics.

Authors:  Ryan Brown; Sridesh Nath; Alnardo Lora; Ghassan Samaha; Ziyad Elgamal; Ryan Kaiser; Clifford Taggart; Sinéad Weldon; Patrick Geraghty
Journal:  Respir Res       Date:  2020-05-12

8.  Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus.

Authors:  Chi-Yuan Chou; Chia-Hui Chien; Yu-San Han; Mojca Trstenjak Prebanda; Hsing-Pang Hsieh; Boris Turk; Gu-Gang Chang; Xin Chen
Journal:  Biochem Pharmacol       Date:  2008-01-19       Impact factor: 5.858

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.